In the context of doxorubicin (DOX)-induced cardiomyopathy, FUNDC2 has been shown to interact with SLC25A11, leading to decreased stability of SLC25A11 and downregulation of mitochondrial GSH, ultimately promoting ferroptosis [20, 119]. This evidence concerns the gene SLC25A11 and cardiomyopathy.